Free Trial
NASDAQ:NDRA

ENDRA Life Sciences (NDRA) Stock Price, News & Analysis

ENDRA Life Sciences logo
$3.47 +0.05 (+1.46%)
As of 02:06 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About ENDRA Life Sciences Stock (NASDAQ:NDRA)

Key Stats

Today's Range
$3.29
$3.55
50-Day Range
$3.09
$7.20
52-Week Range
$2.90
$179.20
Volume
7,604 shs
Average Volume
140,931 shs
Market Capitalization
$2.57 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$50.00
Consensus Rating
Buy

Company Overview

ENDRA Life Sciences Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
63rd Percentile Overall Score

NDRA MarketRank™: 

ENDRA Life Sciences scored higher than 63% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    ENDRA Life Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    ENDRA Life Sciences has only been the subject of 1 research reports in the past 90 days.

  • Read more about ENDRA Life Sciences' stock forecast and price target.
  • Earnings Growth

    Earnings for ENDRA Life Sciences are expected to grow in the coming year, from ($47.46) to ($15.38) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of ENDRA Life Sciences is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of ENDRA Life Sciences is -0.02, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    ENDRA Life Sciences has a P/B Ratio of 0.73. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about ENDRA Life Sciences' valuation and earnings.
  • Percentage of Shares Shorted

    2.29% of the float of ENDRA Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    ENDRA Life Sciences has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ENDRA Life Sciences has recently decreased by 67.12%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    ENDRA Life Sciences does not currently pay a dividend.

  • Dividend Growth

    ENDRA Life Sciences does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    2.29% of the float of ENDRA Life Sciences has been sold short.
  • Short Interest Ratio / Days to Cover

    ENDRA Life Sciences has a short interest ratio ("days to cover") of 0.1, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in ENDRA Life Sciences has recently decreased by 67.12%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    ENDRA Life Sciences has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for ENDRA Life Sciences this week, compared to 0 articles on an average week.
  • MarketBeat Follows

    Only 1 people have added ENDRA Life Sciences to their MarketBeat watchlist in the last 30 days. This is a decrease of -67% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, ENDRA Life Sciences insiders have not sold or bought any company stock.

  • Percentage Held by Insiders

    Only 0.04% of the stock of ENDRA Life Sciences is held by insiders.

  • Percentage Held by Institutions

    Only 1.19% of the stock of ENDRA Life Sciences is held by institutions.

  • Read more about ENDRA Life Sciences' insider trading history.
Receive NDRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ENDRA Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

NDRA Stock News Headlines

ENDRA Life Sciences Inc. (NDRA) - Yahoo Finance
Is Elon's empire crumbling?
The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
ENDRA Life Sciences Inc Registered Shs NDRA
See More Headlines

NDRA Stock Analysis - Frequently Asked Questions

ENDRA Life Sciences' stock was trading at $6.26 at the beginning of the year. Since then, NDRA shares have decreased by 44.6% and is now trading at $3.47.
View the best growth stocks for 2025 here
.

ENDRA Life Sciences Inc. (NASDAQ:NDRA) issued its quarterly earnings results on Monday, March, 31st. The company reported ($9.40) earnings per share (EPS) for the quarter, missing the consensus estimate of ($4.10) by $5.30.

Shares of ENDRA Life Sciences reverse split before market open on Tuesday, August 20th 2024.The 1-50 reverse split was announced on Friday, August 16th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Monday, August 19th 2024. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

ENDRA Life Sciences (NDRA) raised $10 million in an initial public offering on Friday, February 3rd 2017. The company issued 2,000,000 shares at $5.00-$5.50 per share. Dougherty & Company and Dawson James Securities served as the underwriters for the IPO.

Shares of NDRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ENDRA Life Sciences investors own include Bionano Genomics (BNGO), Cocrystal Pharma (COCP), AMC Entertainment (AMC), Plug Power (PLUG), Mustang Bio (MBIO), SNDL (SNDL) and BIOLASE (BIOL).

Company Calendar

Last Earnings
3/31/2025
Today
7/02/2025
Next Earnings (Estimated)
8/13/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Medical Equipment
Current Symbol
NASDAQ:NDRA
Fax
N/A
Employees
20
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$50.00
High Stock Price Target
$50.00
Low Stock Price Target
$50.00
Potential Upside/Downside
+1,366.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$11.51 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Book Value
$4.77 per share
Price / Book
0.71

Miscellaneous

Free Float
738,000
Market Cap
$2.52 million
Optionable
Not Optionable
Beta
-0.18
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report

This page (NASDAQ:NDRA) was last updated on 7/2/2025 by MarketBeat.com Staff
From Our Partners